Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Human Trials and a Look Into the Future

Diabetes Care - United States
doi 10.2337/dc09-0374
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Risk Factors and Primary Prevention Trials for Type 1 Diabetes

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2013English

A Future for CD3 Antibodies in Immunotherapy of Type 1 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Editors’ Picks for 2014 and a Look Into the Future

Cardiology and Therapy
2015English

The Future of Care for Type 1 Diabetes

CMAJ
Medicine
2013English

The Gut Microbiome as a Target for Prevention and Treatment of Hyperglycaemia in Type 2 Diabetes: From Current Human Evidence to Future Possibilities

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Look Into the Future

Chemical and Engineering News
Chemical Engineering
2004English

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Identification of Infants With Increased Type 1 Diabetes Genetic Risk for Enrollment Into Primary Prevention Trials—GPPAD‐02 Study Design and First Results

Pediatric Diabetes
Internal MedicinePediatricsEndocrinologyPerinatologyChild HealthMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy